Fluoxetin (also spelled fluoxetine in some regions) is classified as a Prescription Only Medicine (POM) in the United Kingdom, meaning that it cannot legally be supplied without a valid prescription. Although some online pharmacies advertise “purchase without prescription,” UK regulations require a prescription issued by a qualified prescriber before dispensing fluoxetin. Patients should always ensure they follow national guidelines to avoid purchasing counterfeit or unregulated products.
A Prescription Only Medicine (POM) can only be legally dispensed by a pharmacist in response to a valid prescription from a registered prescriber (e.g., GP, psychiatrist). This classification ensures that medicines like fluoxetin, which have significant pharmacological effects and potential risks, are used under medical supervision. Attempting to purchase POMs without a prescription can lead to legal and health risks, including receiving unsafe or substandard products.
Fluoxetin belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It is widely prescribed for major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa and other conditions. It increases serotonin levels in the brain by inhibiting its reuptake into presynaptic neurons, thereby enhancing mood and emotional regulation.
SSRIs are a group of psychotropic drugs that selectively inhibit the reabsorption (reuptake) of serotonin, a neurotransmitter associated with mood stability. Other SSRIs include sertraline, citalopram, paroxetine, escitalopram and fluvoxamine. SSRIs have largely replaced older antidepressants like tricyclic antidepressants and monoamine oxidase inhibitors due to their improved safety profile.
The active pharmaceutical ingredient is fluoxetine hydrochloride (or fluoxetin hydrochloride). Generic versions contain the same active moiety at approved strengths, though excipients, tablet design and coatings may differ. Branded versions include drugs such as Prozac®.
Fluoxetin can interact with other medicines, has a long elimination half-life, and may cause side effects ranging from mild gastrointestinal upset to rare but serious reactions such as serotonin syndrome. Dose titration, monitoring and tapering require professional oversight to optimize therapeutic benefit and minimize risk.
Fluoxetin is not considered addictive in the classical sense, as it does not produce euphoria or craving. However, abrupt discontinuation after prolonged use can lead to withdrawal-like symptoms such as dizziness, irritability or sensory disturbances, so gradual tapering is recommended under medical guidance.
By modulating serotonin levels, fluoxetin can alleviate a spectrum of psychiatric conditions where serotonin dysregulation is implicated. Its common indications include major depressive disorder, OCD, bulimia nervosa and panic disorder under specialist prescription.
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter that plays a key role in mood, emotion, sleep, appetite and cognition. Imbalances in serotonin pathways are linked to depression, anxiety and other disorders.
Fluoxetin binds to the serotonin transporter (SERT) on presynaptic neurons, blocking serotonin reabsorption into the nerve ending. This increases serotonin concentration in the synaptic cleft, enhancing neurotransmission to postsynaptic receptors.
Although fluoxetin raises synaptic serotonin quickly, clinical improvement usually takes 2–6 weeks of daily dosing. The delay is attributed to adaptive changes in receptor sensitivity and neural circuits over time.
Fluoxetin is highly selective for serotonin reuptake inhibition but can have secondary effects on other systems at higher doses or in rare cases. It has minimal direct impact on norepinephrine or dopamine reuptake.
Fluoxetin has a long elimination half-life (2–7 days for fluoxetine; 7–15 days for its active metabolite, norfluoxetine). This can influence dosing schedules, reduce withdrawal risk but also prolong side effects during tapering or after stopping therapy.
Yes. Concomitant use with other serotonergic drugs (e.g., MAO inhibitors, triptans, St John’s wort) can precipitate serotonin syndrome, a potentially life-threatening condition characterized by agitation, hyperthermia, rapid heart rate and neuromuscular abnormalities. Immediate medical attention is required.
Prices for fluoxetin vary by brand vs. generic status, pack size, dosage strength and the pharmacy’s own pricing structure. Being a Prescription Only Medicine, fluoxetin is only available upon presentation of a valid prescription. Patients may choose generic fluoxetin for a lower cost. Ivybridge Pharmacy offers competitive pricing and fast UK delivery for approved orders.
Differences reflect wholesale procurement costs, manufacturer rebates, pack sizes, patient support services and pharmacy running costs. “Cheaper” does not necessarily mean inferior quality—generic medicines undergo the same regulatory scrutiny as branded equivalents.
| Product | Strength | Pack size | Approx. price (GBP) | Status | Notes |
|---|---|---|---|---|---|
| Fluoxetin 20 mg capsules (generic) | 20 mg | 28 capsules | £8.99 | Prescription Only | Ask Ivybridge Pharmacy for a prescription submission service |
| Prozac® 20 mg capsules | 20 mg | 30 capsules | £22.50 | Prescription Only | Branded product |
Fluoxetin is available in strengths of 10 mg, 20 mg, and 40 mg capsules or tablets. Specialist formulations, such as liquid oral solution, may be available for patients with swallowing difficulties.
Formulation affects patient adherence, dose accuracy and absorption rate. Oral solutions allow dose titration in pediatric or geriatric populations. Capsules and tablets ensure consistent release.
Pack size is regulated according to prescribing guidelines. Short courses or initial titration packs may be limited to 28–30 units, while maintenance prescriptions can supply up to 84 days of therapy at once.
Generics must demonstrate bioequivalence to the reference branded medicine, ensuring equal efficacy and safety. Differences may occur in excipients, colourants and packaging, but active ingredient quality is strictly regulated.
Fluoxetin is commonly prescribed for moderate to severe depression. Treatment aims to restore mood, interest in activities and daily functioning. A typical starting dose is 20 mg once daily, adjusted by the prescriber based on response.
In OCD, fluoxetin helps reduce the frequency and intensity of obsessions and compulsions. Doses may range from 20 mg to 60 mg daily, with specialist monitoring for symptom improvement and side effects.
Fluoxetin is licensed for bulimia at a dose of 60 mg daily to reduce binge-purge cycles. Treatment is usually combined with psychological support and dietary counselling.
Although not licensed for panic disorder in the UK, SSRIs like fluoxetin are used off-label under specialist guidance. Off-label prescribing requires clear documentation and patient consent.
Initial improvements in sleep or anxiety may be noted within 1–2 weeks, but core mood benefits often take 4–8 weeks. Consistent daily dosing and adherence to the prescribed regimen are critical for therapeutic success.
Fluoxetin’s potential for significant interactions, side effects and need for monitoring dictates its status as a Prescription Only Medicine. This ensures patient safety through proper assessment and follow-up.
No. Pharmacists must see a valid prescription from an authorised prescriber. Remote or online pharmacies typically require patients to upload a scanned prescription or use an electronic prescribing service.
The Medicines Act 1968 and subsequent amendments along with MHRA guidelines set out the legal framework for classification, supply and monitoring of POMs in the UK.
Cognitive behavioural therapy (CBT), interpersonal therapy (IPT) and counselling can be effective alone or in combination with pharmacotherapy. Access may be via NHS or private providers.
| Feature | Fluoxetin | Sertraline | Citalopram |
| Half-life | 2–7 days (active metabolite up to 15 days) | 26 hours | 35 hours |
| Common dose | 20–40 mg daily | 50–200 mg daily | 20–40 mg daily |
| Typical side effects | GI upset, insomnia | Diarrhoea, insomnia | Dry mouth, fatigue |
| Withdrawal risk | Lower (long half-life) | Moderate | Moderate |
No. Choice depends on patient history, side effect profiles, comorbidities and drug interactions. For example, fluoxetin’s long half-life may reduce withdrawal risk but complicate dose changes, while other SSRIs may suit rapid titration.
Food does not significantly affect fluoxetin absorption; it can be taken with or without meals. Maintaining a balanced diet supports overall treatment outcomes.
Alcohol can exacerbate depression and increase side effects such as drowsiness. Patients are advised to limit or avoid alcohol during treatment.
Excessive caffeine can worsen anxiety or insomnia. Moderation is recommended, particularly in the initial treatment phase when nervousness may be more pronounced.
Regular physical activity is beneficial for mood and may augment pharmacotherapy effects. Even moderate exercise like walking can yield improvements in depression symptoms.
| System | Common effects |
| Gastrointestinal | Nausea, diarrhoea, dry mouth |
| Central nervous | Insomnia, headache, agitation |
| Sexual | Reduced libido, delayed orgasm |
| Weight | Possible weight changes |
| Rare serious | Serotonin syndrome, hyponatraemia |
Yes. Though rare, hypersensitivity reactions such as rash, itching or anaphylaxis require immediate medical attention.
Regulatory guidance mandates listing all known or suspected adverse reactions. Low-frequency events may occur in fewer than 1 in 10,000 patients but are still documented.
Gradual dose reduction minimizes discontinuation symptoms. A stepwise taper over weeks to months is advised for patients on long-term fluoxetin therapy, based on clinical judgement.
Prolonged SSRI use may affect bone density, bleeding risk or sodium balance in susceptible individuals. Regular review by a prescriber ensures ongoing appropriateness of therapy.
Reviews typically occur 4–6 weeks after initiation, then every 3–6 months. Persistence of symptoms, side effects or patient concerns guide dosage adjustments.
Yes. Fluoxetin inhibits CYP2D6, affecting drugs metabolized via this pathway (e.g., beta-blockers, tricyclics). Clinically significant interactions are detailed in product information.
SSRIs cross the placenta. Risk of neonatal adaptation syndrome exists, so prescribing in pregnancy requires specialist assessment. Breastfeeding mothers should monitor infants for irritability or feeding problems.
Combining multiple serotonergic agents can precipitate serotonin syndrome. Early signs include tremor, hyperreflexia, sweating and confusion. Discontinue all serotonergic meds and seek urgent care.
Generic products contain fluoxetine hydrochloride equivalent to the reference brand, meeting MHRA standards. They may differ in excipients, appearance or packaging but offer the same therapeutic effect.
Different manufacturers and licences can lead to variations in patient information leaflets. Pack size, excipients, indications and legal classification details may vary accordingly.
Reliable sources include the MHRA, the electronic Medicines Compendium (eMC), the British National Formulary (BNF) and qualified healthcare professionals.
No. This page is for general information only. For personalised advice, please speak to the team at Ivybridge Pharmacy, 7 Erme Court, Ivybridge, Devon PL21 0SZ or consult your GP.